Design of the Magnetic Resonance Imaging Evaluation of Mineralocorticoid Receptor Antagonism in Diabetic Atherosclerosis (MAGMA) Trial

Mineralocorticoid receptor (MR) activation plays an essential role in promoting inflammation, fibrosis, and target organ damage. Currently, no studies are investigating MR antagonism in patients with type 2 diabetes mellitus (T2DM) with chronic kidney disease, at high risk for cardiovascular complic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Rajagopalan, Sanjay, Alaiti, M. Amer, Broadwater, Kylene, Goud, Aditya, Gaztanaga, Juan, Connelly, Kim, Fares, Anas, Shirazian, Shayan, Kreatsoulas, Catherine, Farkouh, Michael, Dobre, Mirela, Fink, Jeffrey C., Weir, Matthew R.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2017
Assuntos:
Trial Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6490527/
https://ncbi.nlm.nih.gov/pubmed/28555959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22718
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados